Changes of IL-6 And IFN-γ before and after the adverse events related to immune checkpoint inhibitors: A retrospective study

Immune checkpoint inhibitors (ICIs) have changed the status of tumor immunotherapy. ICIs-related adverse events (irAEs) have the high incidence and are difficult to predict and prevent. Researches have suggested that changes of cytokines were associated with irAEs. This study focused on the changes...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xu, Lu, Xingyu, Yu, Yixuan, Tan, Kexin, Cui, Huijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678612/
https://www.ncbi.nlm.nih.gov/pubmed/36401365
http://dx.doi.org/10.1097/MD.0000000000031761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678612/
https://www.ncbi.nlm.nih.gov/pubmed/36401365
http://dx.doi.org/10.1097/MD.0000000000031761

Ejemplares similares